TIS 0.00% 0.0¢ tissue therapies limited

Not Cricket, page-6

  1. 347 Posts.
    Incompetence at so many critical points can't be explained away as "a few mistakes".

    He has cost many careful investors a lot of money. The institutional investors who bought in at 21c a month ago only to see half their money disappear last week must be molten with anger about how they were led up the garden path by a CEO who obviously didn't have a clue about what the EMA really wanted, nor how to deliver it!

    Unfortunately for us the only thing Mercer was good at was hiding his poor performance.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.